TLB - Overview: Thallium, Blood
Detecting toxic exposure in whole blood specimens
FLUC - Overview: 5-Flucytosine, Serum
Monitoring serum concentration during therapy Evaluating potential toxicity May aid in evaluating patient compliance
VLTU - Overview: Volatile Screen, Random, Urine
Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation
VITE - Overview: Vitamin E, Serum
Monitoring of Vitamin E supplementation/treatment Potentially detecting Vitamin E overdoses
FL - Overview: Fluoride, Plasma
Assessing accidental fluoride ingestion Monitoring patients receiving sodium fluoride for bone disease or patients receiving voriconazole therapy
HMDB - Overview: Heavy Metals Screen with Demographics, Blood
Detecting exposure to arsenic, lead, cadmium, and mercury
MEV1 - Overview: Methemoglobinemia Evaluation, Blood
Diagnosis of methemoglobinemia and sulfhemoglobinemia and possible hereditary (congenital) causes Differentiation of methemoglobinemia and sulfhemoglobinemia from other causes of cyanosis (eg, congenital heart disease)
AMTRP - Overview: Amitriptyline and Nortriptyline, Serum
Monitoring amitriptyline and nortriptyline serum concentrations during therapy Evaluating potential amitriptyline and nortriptyline toxicity May aid in evaluating patient compliance
AMIO - Overview: Amiodarone, Serum
Monitoring amiodarone therapy, especially when amiodarone is coadministered with other drugs that may interact Evaluating possible amiodarone toxicity Assessing patient compliance
ASB - Overview: Arsenic, Blood
Detecting acute or very recent arsenic exposure Monitoring the effectiveness of therapy This test is not useful for evaluation of chronic arsenic exposure.
VITC - Overview: Ascorbic Acid (Vitamin C), Plasma
Identifying vitamin C deficiency
AMPHU - Overview: Amphetamines Confirmation, Random, Urine
Confirming drug exposure involving amphetamines such as amphetamine and methamphetamine, phentermine, pseudoephedrine/ephedrine, methylenedioxyamphetamine (MDA), and methylenedioxymethamphetamine (MDMA)
BUPS - Overview: Buprenorphine Screen, Random, Urine
Screening for drug abuse or use of buprenorphine
BUPM - Overview: Buprenorphine and Norbuprenorphine, Random, Urine
Monitoring of compliance utilizing buprenorphine Detection and confirmation of the illicit use of buprenorphine
BRUTA - Overview: Brucella Total Antibody Confirmation, Agglutination, Serum
Diagnosis of brucellosis
CLD18 - Overview: Claudin 18 (CLDN18) (43-14A), Semi-Quantitative Immunohistochemistry, Manual
Identification of tumor cells expressing claudin 18 As an aid in screening patients who may be eligible for VYLOY (zolbetuximab) treatment
CYSPR - Overview: Cyclosporine, Blood
Monitoring whole blood cyclosporine concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...
CARNP - Overview: Carbapenemase Detection-Carba NP Test, Varies
Confirming carbapenemase production from pure isolates of Enterobacterales or Pseudomonas aeruginosa
CURCU - Overview: Copper/Creatinine Ratio, Random, Urine
Investigation of Wilson disease and obstructive liver disease using a random urine specimen
CRCRU - Overview: Chromium/Creatinine Ratio, Random, Urine
Detecting chromium exposure
CDOU - Overview: Cadmium Occupational Exposure, Random, Urine
Detecting occupational exposure to cadmium using random urine specimens
CLOM - Overview: Clomipramine, Serum
Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose
THCU - Overview: Delta-8 and Delta-9-Carboxy-Tetrahydrocannabinol (THC) Confirmation, Random, Urine
Detection and confirmation of drug use of cannabis/marijuana and to specifically identify and quantify delta-8-carboxy tetrahydrocannabinol (THC-COOH) and delta-9-THC-COOH
DSS - Overview: Drug Screen, Prescription/Over the Counter, Serum
Detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent Qualitatively identifying drugs present in the specimen; quantification of identified drugs, when...
ETGC - Overview: Ethyl Glucuronide Confirmation, Random, Urine
Monitoring abstinence in clinical and justice system settings
ETGS - Overview: Ethyl Glucuronide Screen, Random, Urine
Screening for drug abuse involving alcohol
EEPC - Overview: Eastern Equine Encephalitis Antibody Panel, IgG and IgM, Spinal Fluid
Aiding in the diagnosis of Eastern equine encephalitis using spinal fluid specimens
FS - Overview: Fungal Smear, Varies
Detection of fungi in clinical specimens
GABA - Overview: Gabapentin, Serum
Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients
LAMO - Overview: Lamotrigine, Serum
Monitoring serum concentration of lamotrigine Assessing compliance Adjusting lamotrigine dose in patients receiving other anticonvulsant drugs that interact pharmacokinetically with lamotrigine
PBCU - Overview: Lead/Creatinine Ratio, Urine
Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.
MPHNU - Overview: Methylphenidate and Metabolite, Random, Urine
Monitoring urine methylphenidate and ritalinic acid concentrations to assess compliance in patients
Aiding in the evaluation of iron deficiency and iron overload diseases in combination with total iron binding capacity and percent saturation Assessment of acute iron poisoning
ITCON - Overview: Itraconazole, Serum
Verifying systemic absorption of orally administered itraconazole Patients with life-threatening fungal infections Patients considered at risk for poor absorption or rapid clearance of itraconazole
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with neuroendocrine tumors of the pancreas or gastrointestinal tract including metastases
MET - Overview: Methemoglobin and Sulfhemoglobin, Blood
Diagnosing methemoglobinemia and sulfhemoglobinemia Identifying cyanosis due to other causes, such as congenital heart disease
HGU - Overview: Mercury, 24 Hour, Urine
Detecting mercury toxicity using 24-hour urine specimens
MPA - Overview: Mycophenolic Acid, Serum
Monitoring therapy to ensure adequate blood levels and avoid over-immunosuppression
NICOS - Overview: Nicotine and Metabolites, Serum
Monitoring tobacco use in a clinical setting
SIIRO - Overview: Sirolimus, Whole Blood
Monitoring whole blood sirolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...
MNCU - Overview: Manganese/Creatinine Ratio, Urine
Measurement of manganese as a part of a profile Monitoring manganese exposure Nutritional monitoring Clinical trials
TAKRO - Overview: Tacrolimus, Blood
Monitoring whole blood tacrolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...
POSA - Overview: Posaconazole, Serum
Monitoring posaconazole therapy
HPP - Overview: Pancreatic Polypeptide, Plasma
Detecting pancreatic endocrine tumors Assessing vagal nerve function after meal or sham feeding
FRT4 - Overview: T4 (Thyroxine), Free, Serum
Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone
TLU - Overview: Thallium, 24 Hour, Urine
Detecting toxic thallium exposure in 24-hour urine collections
THEO - Overview: Theophylline, Serum
Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity
VLTB - Overview: Volatile Screen, Blood
Detection and quantitation of acetone, methanol, isopropanol, and ethanol in whole blood Quantification of the concentration of ethanol in blood that correlates with the degree of intoxication Evaluation of toxicity to the measured...
VITA - Overview: Vitamin A, Serum
Diagnosing vitamin A deficiency and toxicity Monitoring vitamin A therapy
PETH - Overview: Phosphatidylethanol Confirmation, Blood
Verifying abstinence or use of ethanol, especially in liver transplant candidates/patients
Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights
announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....
the American Academy of Neurology Annual Meeting 2023 - Insights
Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023....
Register today for Classical Hematology 2023 - Insights
Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...
the American Academy of Neurology Annual Meeting 2023 - Insights
the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023....
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory...